⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TNXP News
Tonix Pharmaceuticals Holding Corp.
Form 8-K
sec.gov
TNXP
Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer
globenewswire.com
TNXP
Tonix Pharmaceuticals to Participate in Cantor’s 2026 Global Healthcare Conference
globenewswire.com
TNXP
Form 8-K
sec.gov
TNXP
Form 8-K
sec.gov
TNXP
Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences
globenewswire.com
TNXP
Form 8-K
sec.gov
TNXP
Tonix Pharmaceuticals Announces Positive Minutes from Type C FDA Meeting to Discuss Adaptive Phase 2 Field Study of TNX-4800, a Human, anti-OspA Monoclonal Antibody, to Prevent Lyme Disease in the U.S.
globenewswire.com
TNXP
Tonix Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 10, 2026
globenewswire.com
TNXP
Form 8-K
sec.gov
TNXP